norethindrone and Breast Neoplasms

norethindrone has been researched along with Breast Neoplasms in 105 studies

Research

Studies (105)

Timeframe	Studies, this research(%)	All Research%
pre-1990	58 (55.24)	18.7374
1990's	11 (10.48)	18.2507
2000's	17 (16.19)	29.6817
2010's	15 (14.29)	24.3611
2020's	4 (3.81)	2.80

Authors

Authors	Studies
Chamness, GC; Salman, M	1
Combs, DW; Cornelius, LA; Cryan, EV; Demarest, KT; Granger, KS; Gunnet, JW; Jordan, JJ; Reese, K	1
Gu, M; Mueck, AO; Ruan, X; Zhang, L	1
Cassidy, S; Gursul, D; Saul, H; Vinogradova, Y	1
Africander, D; Jackson, H; Louw-du Toit, R; Perkins, MS; Simons, M	1
Heikinheimo, O; Holopainen, E; Huvinen, E	1
Croteau, S; Gu, M; Hardy, P; Jia, C; Li, X; Ruan, X; Wang, L; Yang, C	1
Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y	1
Price, T	1
Cahill, MA; Fehm, T; Hyder, SM; Liang, Y; Mafuvadze, B; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H	1
Cahill, MA; Chen, R; Fehm, T; Mueck, AO; Neubauer, H; Seeger, H; Yu, Q; Zhou, J	1
Chen, FP; Chen, HY; Chien, MH; Huang, TS; Ng, YT	1
Fan, P; Jordan, VC; Sweeney, EE	1
Carlström, K; Conner, P; Löfgren, L; Lundström, E; Naessén, S; Söderqvist, G	1
Graff-Iversen, S; Hofvind, S; Román, M; Sakshaug, S; Ursin, G; Vangen, S; Weiderpass, E	1
Johansen, OE; Qvigstad, E	1
Dyba, T; Lyytinen, H; Pukkala, E; Ylikorkala, O	1
Karssemeijer, N; Kenemans, P; Otten, JD; van der Mooren, MJ; van Dijck, JA; Verbeek, AL	1
De Geyter, C; De Napoli, G; de Weerd, V; Foekens, JA; Kloosterboer, HJ; Martens, JW; Sieuwerts, AM; van Galen, A; Zhang, H	1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Schultz, S; Seeger, H; Yang, Y	1
Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL	1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H	1
Meyer, KK	1
Kaunitz, AM	1
Basta, A; Gregoraszczuk, EL; Kolodziejczyk, J; Krzysiek, J; Kurek, S; Milewicz, T; Stachura, J; Sztefko, K	1
Mueck, AO; Seeger, H; Wallwiener, D	2
Lynge, E; Ottesen, B; Pederson, AT; Stahlberg, C	1
DOUGLAS, M; LORAINE, JA; STRONG, JA	1
CURWEN, S	2
ONO, S	1
Franke, HR; Vermes, I	1
Mueck, AO; Rakov, V; Seeger, H	1
Honkanen, R; Kröger, H; Pentti, K; Saarikoski, S; Sandini, L; Tuppurainen, MT	1
Franke, HR; Vermes, I; Werner, HM	1
Abdallah, MA; Abdullah, HI; Gercel-Taylor, C; Kang, S; Nakajima, ST; Taylor, DD	1
Arriagada, R; Dobaczewska, D; Fjosne, HE; Hammar, M; Holmberg, L; Holmqvist, M; Iversen, OE; Jaskiewicz, J; Jassem, J; Kumpulainen, E; Maenpa, J; Maenpaa, J; Peralta, O; Rudenstam, CM	1
Casey, CL; Murray, CA	1
Kaigas, M; Notter, G	1
Dudley, B	1
Duke, A; Henderson, BE; Krailo, MD; Pike, MC; Roy, S	1
Fraser, IS	1
Asselain, B; Bretaudeau, B; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P	1
Fraser, IS; Weisberg, E	1
Earl, HM; Hayward, JL; Knight, RK; Rubens, RD	1
Wingrave, SJ	1
Clavel, B; Milgrom, E; Pallud, C; Pichon, MF	1
De-Wei, Z	1
Bonadonna, G; Mauri, M; Tancini, G; Varini, M	1
Biglia, N; Campagnoli, C; Lanza, MG; Lesca, L; Peris, C; Sismondi, P	1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG	2
Hyder, SM; Murthy, L; Stancel, GM	1
Ashley, S; Athanasiou, S; Bourne, T; Chang, J; Collins, W; Davey, J; Gruböck, K; Humphries, S; Oakes, L; Powles, TJ; Tidy, A; Viggers, J	1
Deckers, GH; Kloosterboer, HJ; Schoonen, WG	1
de Gooijer, ME; de Ries, R; Deckers, GH; Kloosterboer, HJ; Schoonen, WG	1
Bai, J; Montell, DJ; Uehara, Y	1
Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D	2
Langlands, AO; Martin, WM	1
Begent, RH; Hayward, JL; Knight, RK; Rubens, RD; Sexton, SA	1
Begent, RH; Cantwell, BM; Rubens, RD	1
Di Pietro, S; Mauri, M; Tancini, G; Varini, M	1
Bohnet, HG; del Pozo, E; Naber, NG; Schneider, HP	1
Degueldre, M; Delvoye, P; Hubinont, PO; L'Hermite, M; Robyn, C; Vekemans, M	1
Hayward, JL; Knight, RK; Rubens, RD	1
Dondlinger, T; Liskowski, L; Olenick, JS; Rose, DP	1
Edelstyn, GA; MacRae, KD	2
Jeng, MH; Jordan, VC; Parker, CJ	1
Jeng, MH; Jordan, VC	1
Ghilchik, MW; James, VH; Lai, LC; Reed, MJ; Ross, MS	1
da Luz, RJ; Rubens, RD	1
Gürtler, R; Schmidt, UM; Stier, G	1
Plowman, PN	1
Carpenter, JT	1
Vorherr, H	1
Gambrell, RD	2
Hammann, P; Hoppen, HO	1
Nillius, SJ	1
Howell, A; Ribeiro, G	1
Avery, GS; Brogden, RN; Speight, TM	1
Guérin, MT; Guérin, RA	1
Aristoff, H; Bloch-Michel, H; Dussart, N; Gorins, A	1
Bourdin, JS; Clavel, B	1
Stoll, BA	2
Prahl, B; Wolff, G	1
Bourjat, P; Gautherie, M; Gros, C; Quenneville, Y	1
Edelstyn, GA	1
Lemaire, V; Ryckewaert, A	1
Edelstyn, GA; Marcrae, KD	1
Dargent, M; Pommatau, E; Servonnat, F	1
Burrows, BD; Edelstyn, GA; Gillespie, PJ	1
Ehlers, PN	1
Cretin, J; Grimand, PS; Michel, PJ	1
Notter, G; Wicklund, H	1
Gorins, A; Netter, A	1
Gregg, WI	1

Reviews

11 review(s) available for norethindrone and Breast Neoplasms

Article	Year
Norethisterone and its acetate - what's so special about them? BMJ sexual & reproductive health, 2021, Volume: 47, Issue:2 Topics: Biological Factors; Breast Neoplasms; Contraceptive Agents, Hormonal; Endometrium; Female; Humans; Norethindrone; Norethindrone Acetate; Thrombosis	2021
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in therapy, 2008, Volume: 25, Issue:6 Topics: Antidepressive Agents; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Humans; Menopause; Norethindrone; Norethindrone Acetate	2008
Hormone replacement therapy and risk of breast cancer: the role of progestins. Acta obstetricia et gynecologica Scandinavica, 2003, Volume: 82, Issue:7 Topics: Breast Neoplasms; Drug Administration Schedule; Epidemiologic Studies; Estrogen Replacement Therapy; Europe; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Meta-Analysis as Topic; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Risk Factors; United States	2003
HT update: spotlight on estradiol/norethindrone acetate combination therapy. Clinical interventions in aging, 2008, Volume: 3, Issue:1 Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Norethindrone; Norethindrone Acetate; Risk Assessment; Stroke; Venous Thromboembolism	2008
Long acting injectable hormonal contraceptives. Clinical reproduction and fertility, 1982, Volume: 1, Issue:1 Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms	1982
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. The Medical journal of Australia, 1981, 01-24, Volume: 1, Issue:SP1 Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms	1981
Progestational agents in the treatment of breast cancer. Cancer treatment and research, 1988, Volume: 39 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins	1988
The menopause. Investigative radiology, 1986, Volume: 21, Issue:4 Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms	1986
Gonadotrophin-releasing hormone agonists for new approaches to contraception in man. Wiener klinische Wochenschrift, 1985, Dec-06, Volume: 97, Issue:23 Topics: Abortion, Induced; Administration, Intranasal; Breast Neoplasms; Buserelin; Contraception; Corpus Luteum; Erectile Dysfunction; Female; Hormones; Humans; Male; Norethindrone; Oligospermia; Ovulation; Pituitary Hormone-Releasing Hormones; Risk; Testosterone	1985
Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone. Drugs, 1973, Volume: 6, Issue:3 Topics: Breast Neoplasms; Chlormadinone Acetate; Contraceptives, Oral; Corpus Luteum; Dose-Response Relationship, Drug; Female; Fertility; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Mucus; Norethindrone; Norgestrel; Pregnancy; Thromboembolism; Vaginal Neoplasms	1973
Hormonal therapy of gynecologic malignancy. Clinical obstetrics and gynecology, 1973, Volume: 16, Issue:4 Topics: Administration, Oral; Adrenal Cortex Hormones; Breast Neoplasms; Carcinoma in Situ; Dimethisterone; Drug Therapy, Combination; Estrogens; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone; Neoplasm Metastasis; Norethindrone; Norpregnanes; Progesterone; Prolactin; Recurrence; Uterine Neoplasms; Uterus	1973

Trials

13 trial(s) available for norethindrone and Breast Neoplasms

Article	Year
Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy. Climacteric : the journal of the International Menopause Society, 2011, Volume: 14, Issue:6 Topics: Administration, Intranasal; Administration, Oral; Breast Neoplasms; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Mammography; Middle Aged; Norethindrone; Postmenopause	2011
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women. Molecular oncology, 2011, Volume: 5, Issue:6 Topics: Breast; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Risk Factors	2011
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ (Clinical research ed.), 2012, Oct-09, Volume: 345 Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Follow-Up Studies; Heart Failure; Hormone Replacement Therapy; Hospitalization; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Risk; Stroke; Time Factors; Treatment Outcome; Venous Thrombosis	2012
Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. Journal of the National Cancer Institute, 2008, Apr-02, Volume: 100, Issue:7 Topics: Adult; Aged; Breast Neoplasms; Confidence Intervals; Confounding Factors, Epidemiologic; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Neoplasm Recurrence, Local; Norethindrone; Odds Ratio; Research Design; Risk Assessment; Risk Factors; Scandinavian and Nordic Countries; Survivors	2008
[The treatment of inoperable and metastasizing breast carcinoma with gestational and estrogenci hormones]. Munchener medizinische Wochenschrift (1950), 1966, Sep-30, Volume: 108, Issue:39 Topics: Aged; Breast Neoplasms; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Norethindrone; Progesterone	1966
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones]. Bulletin du cancer, 1984, Volume: 71, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Norethindrone; Tamoxifen; Teniposide; Vincristine	1984
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners. Acta obstetricia et gynecologica Scandinavica. Supplement, 1982, Volume: 105 Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis	1982
Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. Maturitas, 1994, Volume: 19, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Climacteric; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Norethindrone; Norethindrone Acetate; Risk Factors; Sex Hormone-Binding Globulin	1994
The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. British journal of cancer, 1998, Volume: 78, Issue:2 Topics: Aged; Breast Neoplasms; Double-Blind Method; Endometrium; Estrogen Antagonists; Female; Humans; Middle Aged; Norethindrone; Postmenopause; Tamoxifen; Ultrasonography	1998
Combined cytotoxic and progestogen therapy for advanced breast cancer. Cancer, 1978, Volume: 42, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Norethindrone; Remission, Spontaneous; Time Factors; Vincristine	1978
[Experience in the treatment of metastatic breast carcinoma with norethisterone acetate in a clinical study]. Archiv fur Geschwulstforschung, 1989, Volume: 59, Issue:2 Topics: Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Menopause; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate; Remission Induction; Time Factors	1989
The menopause. Investigative radiology, 1986, Volume: 21, Issue:4 Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms	1986
[A controlled clinical trial for hormonal and combined cyclophosphamide-hormonal treatment of incurable breast cancer (author's transl)]. Archiv fur Geschwulstforschung, 1973, Volume: 41, Issue:4 Topics: Androgens; Breast Neoplasms; Castration; Cyclophosphamide; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Nandrolone; Neoplasm Metastasis; Norethindrone; Propionates; Time Factors	1973

Other Studies

82 other study(ies) available for norethindrone and Breast Neoplasms

Article	Year
A potential radioiodinated ligand for androgen receptor: 7 alpha-methyl-17 alpha-(2'-(E)-iodovinyl)-19-nortestosterone. Journal of medicinal chemistry, 1991, Volume: 34, Issue:3 Topics: Animals; Binding, Competitive; Breast Neoplasms; Chemical Phenomena; Chemistry; Dihydrotestosterone; Female; Humans; Iodine Radioisotopes; Molecular Structure; Nandrolone; Rats; Rats, Inbred Strains; Receptors, Androgen; Tumor Cells, Cultured; Uterus	1991
Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors. Journal of medicinal chemistry, 1995, Dec-08, Volume: 38, Issue:25 Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Drug Design; Female; Humans; Ligands; Progestins; Pyridazines; Receptors, Progesterone; Structure-Activity Relationship; Tumor Cells, Cultured	1995
E2 + norethisterone promotes the PI3K-AKT pathway via PGRMC1 to induce breast cancer cell proliferation. Climacteric : the journal of the International Menopause Society, 2022, Volume: 25, Issue:5 Topics: Breast Neoplasms; Cell Proliferation; Female; Humans; MCF-7 Cells; Membrane Proteins; Norethindrone; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Progesterone	2022
Risk of breast cancer with HRT depends on therapy type and duration. BMJ (Clinical research ed.), 2022, 03-08, Volume: 376 Topics: Age Factors; Aged; Breast Neoplasms; Case-Control Studies; Dydrogesterone; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Progestins; Risk Factors; Time Factors	2022
Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha. Frontiers in endocrinology, 2022, Volume: 13 Topics: Breast Neoplasms; Cathepsin D; Estradiol; Estrogen Receptor alpha; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Up-Regulation	2022
Micro-RNA-181a suppresses progestin-promoted breast cancer cell growth. Maturitas, 2018, Volume: 114 Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; MCF-7 Cells; Membrane Proteins; MicroRNAs; Norethindrone; Progestins; Receptors, Progesterone	2018
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study. Maturitas, 2019, Volume: 123 Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone	2019
Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved? Menopause (New York, N.Y.), 2013, Volume: 20, Issue:5 Topics: Animals; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Female; Humans; Membrane Proteins; Norethindrone; Receptors, Progesterone	2013
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:5 Topics: Animals; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estradiol; Estrogens; Female; Gene Expression; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Nude; Norethindrone; Receptors, Progesterone; Transfection; Tumor Burden	2013
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas, 2013, Volume: 76, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Female; Formazans; Humans; Intercellular Signaling Peptides and Proteins; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Progesterone; Receptor Cross-Talk; Receptors, Progesterone; Tetrazolium Salts	2013
Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. Taiwanese journal of obstetrics & gynecology, 2013, Volume: 52, Issue:3 Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Proliferation; Cell Transformation, Neoplastic; Cyproterone Acetate; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Progesterone	2013
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study. Cancer research, 2014, Dec-01, Volume: 74, Issue:23 Topics: Apoptosis; Breast Neoplasms; Dexamethasone; Estrogens; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Receptors, Estrogen; Receptors, Glucocorticoid; Risk; Women's Health	2014
Estrone - a partial estradiol antagonist in the normal breast. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:9 Topics: Aged; Breast; Breast Density; Breast Neoplasms; Contraceptives, Oral; Drug Combinations; Estradiol; Estriol; Estrogen Antagonists; Estrogen Replacement Therapy; Estrone; Female; Humans; Mammary Glands, Human; Mammography; Middle Aged; Norethindrone	2015
Postmenopausal hormone therapy and the risk of breast cancer in Norway. International journal of cancer, 2016, Feb-01, Volume: 138, Issue:3 Topics: Aged; Breast Neoplasms; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Risk	2016
Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: national-wide case-control study from Finland. International journal of cancer, 2010, Jul-01, Volume: 127, Issue:1 Topics: Breast Neoplasms; Case-Control Studies; Estrogen Replacement Therapy; Female; Finland; Humans; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Registries	2010
Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:5 Topics: Breast Neoplasms; Cell Membrane; Cell Proliferation; Female; Gene Expression; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Receptors, Progesterone; Transfection	2012
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins	2013
Breast cancer manifest during contraceptive steroid therapy of two women with prior lactation mastitis. Guthrie Clinic bulletin, 1969, Volume: 39, Issue:1 Topics: Breast; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dimethisterone; Disease; Ethinyl Estradiol; Family Planning Services; Lactation; Neoplasms; Norethindrone; Puerperal Disorders; Research	1969
Injectable contraception: the USA perspective. IPPF medical bulletin, 1992, Volume: 26, Issue:6 Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service	1992
Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:4 Topics: Breast; Breast Neoplasms; Cyproterone; Female; Human Growth Hormone; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Levonorgestrel; Medroxyprogesterone; Norethindrone; Progesterone; Progesterone Congeners; Receptors, Estrogen	2002
The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003, Volume: 35, Issue:2 Topics: Analysis of Variance; Breast Neoplasms; Cell Division; Chlormadinone Acetate; Culture Media; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progestins; Tumor Cells, Cultured	2003
Studies with 19-norethisterone oenanthate in mammary carcinoma. Proceedings of the Royal Society of Medicine, 1960, Volume: 53 Topics: Breast; Breast Neoplasms; Humans; Norethindrone; Progesterone	1960
THE VALUE OF NORETHISTERONE ACETATE IN THE TREATMENT OF ADVANCED CARCINOMA OF THE BREAST. Clinical radiology, 1963, Volume: 14 Topics: Adrenalectomy; Breast; Breast Neoplasms; Carcinoma; Geriatrics; Humans; Hypophysectomy; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate; Toxicology	1963
[STUDIES ON THE EXTRAGONADAL ESTROGENS]. Nihon Naibunpi Gakkai zasshi, 1963, Nov-20, Volume: 39 Topics: Adrenal Cortex Hormones; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Breast Neoplasms; Castration; Chemical Phenomena; Chemistry; Cushing Syndrome; Estradiol; Estriol; Estrogens; Estrone; Female; Gonadotropins; Gonadotropins, Equine; Horses; Humans; Hysterectomy; Menstruation; Norethindrone; Ovary; Pharmacology; Physiology; Surgical Procedures, Operative; Urine; Uterine Neoplasms	1963
Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:3 Topics: Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Equilin; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progestins; Tumor Cells, Cultured	2003
Differential effects of progestogens on breast cancer cell lines. Maturitas, 2003, Dec-10, Volume: 46 Suppl 1 Topics: Apoptosis; Breast Neoplasms; Cell Division; Contraceptives, Oral, Synthetic; Estradiol; Humans; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Tumor Cells, Cultured	2003
Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2005, Volume: 37, Issue:8 Topics: Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Epithelial Cells; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone	2005
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study. European journal of endocrinology, 2006, Volume: 154, Issue:1 Topics: Aged; Breast Neoplasms; Cohort Studies; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Levonorgestrel; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies	2006
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured	2005
Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. Fertility and sterility, 2007, Volume: 87, Issue:4 Topics: Breast Neoplasms; Cell Line, Tumor; Equilin; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone	2007
Treatment of the artificial menopause. The Practitioner, 1967, Volume: 198, Issue:187 Topics: Barbiturates; Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Menopause; Middle Aged; Norethindrone; Trifluoperazine	1967
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (London, England), 1983, Oct-22, Volume: 2, Issue:8356 Topics: Adult; Age Factors; Breast; Breast Neoplasms; Contraceptives, Oral; Drug Combinations; Endometrium; Female; Humans; Mitosis; Norethindrone; Norethindrone Acetate; Ovary; Pregnancy; Risk; Time Factors	1983
Long-acting progestins--promise and prospects. Population reports. Series K, Injectables and implants, 1983, Volume: 11, Issue:2 Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms	1983
Norethisterone acetate in the treatment of advanced breast cancer. Clinical oncology, 1984, Volume: 10, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Hypophysectomy; Middle Aged; Norethindrone; Norethindrone Acetate; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies	1984
Estradiol and progesterone receptors content and response to norethisterone treatment in advanced breast cancer. European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:9 Topics: Adult; Aged; Breast Neoplasms; Estradiol; Female; Humans; Male; Middle Aged; Norethindrone; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone	1982
Research activities in the field of oral contraceptives in the People's Republic of China. Acta obstetricia et gynecologica Scandinavica. Supplement, 1982, Volume: 105 Topics: Abnormalities, Drug-Induced; Breast Neoplasms; China; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Delayed-Action Preparations; Female; Genital Neoplasms, Female; Humans; Megestrol; Norethindrone; Research	1982
[Oral gestagen treatment of advanced breast neoplasms with norethisterone acetate]. Schweizerische medizinische Wochenschrift, 1980, Jul-08, Volume: 110, Issue:27-28 Topics: Administration, Oral; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Norethindrone	1980
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	1995
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured	1995
Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer research, 1998, Feb-01, Volume: 58, Issue:3 Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals. The Journal of steroid biochemistry and molecular biology, 2000, Volume: 74, Issue:3 Topics: Animals; Biological Assay; Breast Neoplasms; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Female; Humans; Hydrocarbons; Injections, Subcutaneous; Ligands; Male; Methane; Methylation; Norethindrone; Orchiectomy; Organ Size; Ovarian Follicle; Ovulation; Progesterone; Prostate; Protein Binding; Rabbits; Rats; Receptors, Androgen; Receptors, Progesterone; Substrate Specificity; Transcriptional Activation; Tumor Cells, Cultured	2000
Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives. The Journal of steroid biochemistry and molecular biology, 2000, Nov-15, Volume: 74, Issue:4 Topics: Administration, Oral; Animals; Breast Neoplasms; Cell Division; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Female; Humans; Injections, Subcutaneous; Male; Norethindrone; Orchiectomy; Ovariectomy; Ovulation; Progesterone Congeners; Rabbits; Rats; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship; Transcriptional Activation; Tumor Cells, Cultured	2000
Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. Cell, 2000, Dec-22, Volume: 103, Issue:7 Topics: Animals; Base Sequence; Breast Neoplasms; Cadherins; Cell Movement; Drosophila; Drosophila Proteins; Female; Gene Expression Regulation, Developmental; Genetic Testing; Molecular Sequence Data; Mosaicism; Mutation; Norethindrone; Nuclear Receptor Coactivator 3; Ovary; Ovum; Phenotype; Receptors, Steroid; Transcription Factors; Transcriptional Activation	2000
The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment. European journal of gynaecological oncology, 2001, Volume: 22, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Progestins; Tumor Cells, Cultured	2001
Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells. European journal of gynaecological oncology, 2002, Volume: 23, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Female; Humans; Norethindrone; Norpregnenes; Progesterone Congeners; Tumor Cells, Cultured	2002
Letter: Jaundice associated with norethisterone-acetate treatment of breast cancer. Lancet (London, England), 1975, Mar-08, Volume: 1, Issue:7906 Topics: Acetates; Breast Neoplasms; Female; Humans; Jaundice; Norethindrone; Time Factors	1975
Augmentation of vincristine-induced thrombocytosis by norethisterone. European journal of cancer, 1979, Volume: 15, Issue:8 Topics: Adult; Aged; Breast Neoplasms; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Middle Aged; Norethindrone; Platelet Count; Thrombocytosis; Thromboembolism; Time Factors; Vincristine	1979
Treatment of advanced breast cancer with norethisterone acetate. Tumori, 1979, Dec-31, Volume: 65, Issue:6 Topics: Age Factors; Aged; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate	1979
Effects of synthetic gestagens on serum prolactin and growth hormone secretion in amenorrheic patients. Archives of gynecology, 1978, Nov-30, Volume: 226, Issue:3 Topics: Amenorrhea; Breast Neoplasms; Female; Growth Hormone; Humans; Medroxyprogesterone; Metoclopramide; Norethindrone; Norgestrel; Prolactin; Radioimmunoassay	1978
[Clinical pharmacology of hormonal contraceptives]. Bulletin et memoires de l'Academie royale de medecine de Belgique, 1975, Volume: 130, Issue:7-9 Topics: Adult; Aged; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Medroxyprogesterone; Middle Aged; Norethindrone; Norgestrel; Prolactin	1975
Norethisterone acetate in the treatment of advanced breast cancer. European journal of cancer, 1976, Volume: 12, Issue:7 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hypophysectomy; Middle Aged; Neoplasm Metastasis; Norethindrone; Remission, Spontaneous; Skin Neoplasms	1976
The determination of progesterone receptors in breast cancer and their relationship to estrogen receptors. Clinica chimica acta; international journal of clinical chemistry, 1976, Sep-06, Volume: 71, Issue:2 Topics: Adult; Aged; Breast Neoplasms; Cell Nucleus; Cytoplasm; Female; Humans; Hydrocortisone; Middle Aged; Norethindrone; Progesterone; Protein Binding; Transcortin	1976
"Early" and "late" breast cancer: a unified concept for treatment. Clinical radiology, 1976, Volume: 27, Issue:4 Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Hypophysectomy; Methotrexate; Neoplasm Metastasis; Norethindrone; Time Factors; Vincristine	1976
Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer research, 1992, Dec-01, Volume: 52, Issue:23 Topics: Amino Acid Sequence; Breast Neoplasms; Cell Division; Chloramphenicol O-Acetyltransferase; Dose-Response Relationship, Drug; Enzyme Induction; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Protein-Tyrosine Kinases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured	1992
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Molecular endocrinology (Baltimore, Md.), 1991, Volume: 5, Issue:8 Topics: Breast Neoplasms; Cell Division; Estradiol; Gene Expression Regulation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured	1991
In vivo conversion of norethisterone to ethynyloestradiol in perimenopausal women. The Journal of steroid biochemistry and molecular biology, 1990, Volume: 37, Issue:2 Topics: Biotransformation; Breast Neoplasms; Carbon Radioisotopes; Ethinyl Estradiol; Female; Humans; Menopause; Norethindrone	1990
Norethisterone acetate as secondary endocrine treatment in advanced breast cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Ovariectomy; Prednisolone; Tamoxifen	1989
Treatment of menopausal symptoms in breast cancer patients. Lancet (London, England), 1988, Jul-16, Volume: 2, Issue:8603 Topics: Breast Neoplasms; Climacteric; Clonidine; Female; Humans; Norethindrone	1988
Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. American journal of obstetrics and gynecology, 1986, Volume: 154, Issue:1 Topics: Adenofibroma; Adenoma; Adult; Aged; Breast; Breast Neoplasms; Bromocriptine; Contraceptives, Oral, Combined; Cysts; Danazol; Epithelium; Estrogens; Female; Fibrocystic Breast Disease; Humans; Hyperplasia; Mammography; Mastectomy; Middle Aged; Nipples; Norethindrone; Papilloma; Progesterone; Progestins; Prolactin; Thyroid Hormones; Ultrasonography; Vitamin E; Xanthines	1986
Use of progestogen therapy. American journal of obstetrics and gynecology, 1987, Volume: 156, Issue:5 Topics: Breast Neoplasms; Cholesterol, HDL; Drug Therapy, Combination; Estrogens; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Risk; Uterine Neoplasms	1987
The influence of structural modification on progesterone and androgen receptor binding of norethisterone. Correlation with nuclear magnetic resonance signals. Acta endocrinologica, 1987, Volume: 115, Issue:3 Topics: Binding, Competitive; Breast Neoplasms; Chemical Phenomena; Chemistry; Endometrium; Female; Humans; Magnetic Resonance Spectroscopy; Norethindrone; Radioligand Assay; Receptors, Androgen; Receptors, Progesterone	1987
Oral contraception, 1986. Endocrinology and pharmacology. A panel discussion. The Journal of reproductive medicine, 1986, Volume: 31, Issue:6 Suppl Topics: Adult; Animals; Breast Neoplasms; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Mestranol; Middle Aged; Norethindrone; Norgestrel; Rats; Risk	1986
Management of advanced carcinoma of the breast. The Practitioner, 1985, Volume: 229, Issue:1401 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Neoplasm Recurrence, Local; Norethindrone; Norethindrone Acetate; Tamoxifen	1985
Hormones in advanced cancer. British medical journal, 1971, Jun-26, Volume: 2, Issue:5764 Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adrenalectomy; Androgens; Androstanols; Breast Neoplasms; Estrogens; Female; Hirsutism; Hormones; Humans; Hypercalcemia; Hypertension; Hypophysectomy; Male; Nandrolone; Norethindrone; Ovarian Neoplasms; Progesterone; Prostatic Neoplasms; Thyroid Hormones; Thyroid Neoplasms; Urogenital Neoplasms; Uterine Neoplasms; Vasopressins	1971
[Use of progestational hormones in the treatment of advanced stages of breast and gynaecologic carcinoma]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1969, Dec-14, Volume: 45, Issue:51 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Norethindrone; Ovarian Neoplasms; Pleural Neoplasms; Progestins; Skin Neoplasms; Uterine Neoplasms	1969
[Therapeutic possibilities in metastatic cancer of the breast with hypercalcaemia. (Apropos of 2 cases)]. Revue du rhumatisme et des maladies osteo-articulaires, 1969, Volume: 36, Issue:11 Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Bone Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Estrogens; Female; Humans; Hypercalcemia; Middle Aged; Neoplasm Metastasis; Norethindrone; Ovary; Phosphoric Monoester Hydrolases; Phosphorus; Prednisone; Radiography; Testosterone	1969
[Progestogens in the treatment of advanced breast cancer. Clinical study of norethisterone acetate]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1970, Jan-14, Volume: 46, Issue:3 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Tolerance; Estrogens; Female; Hormones; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Norethindrone; Radiography; Skin Neoplasms	1970
[Thermogenic capacity of breast carcinomas. II. Variation during hormonal tests]. Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1973, Volume: 18, Issue:5 Topics: Adult; Aged; Androgens; Body Temperature; Breast Neoplasms; Estrogens; Ethinyl Estradiol; Female; Fluoxymesterone; Humans; Middle Aged; Norethindrone; Phosphorus; Phosphorus Radioisotopes; Skin Temperature; Testosterone; Thermography; Thermometers	1973
Norethisterone acetate (SH420) in advanced breast cancer. Cancer, 1973, Volume: 32, Issue:6 Topics: Age Factors; Bone Neoplasms; Breast Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Neoplasm Metastasis; Norethindrone; Remission, Spontaneous; Time Factors	1973
Cyclical combination chemotherapy in advanced breast cancer. British journal of cancer, 1973, Volume: 28, Issue:5 Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Hypophysectomy; Methotrexate; Norethindrone; Remission, Spontaneous; Time Factors; Vincristine	1973
[Treatment of bone metastases of breast cancer with progestogens]. Revue du rhumatisme et des maladies osteo-articulaires, 1974, Volume: 41, Issue:1 Topics: Adult; Aged; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Calcium; Female; Humans; Middle Aged; Neoplasm Metastasis; Norethindrone; Pain; Prognosis; Remission, Spontaneous; Time Factors	1974
Cyclical combination chemotherapy in advanced breast cancer. Annals of the Royal College of Surgeons of England, 1974, Volume: 54, Issue:6 Topics: Age Factors; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hypophysectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Norethindrone; Vincristine	1974
[Results of norethindrone (norluten) treatment of diffusion phase breast cancer]. Bulletin de l'Academie nationale de medecine, 1968, Mar-19, Volume: 152, Issue:11 Topics: Adult; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Norethindrone; Time Factors	1968
Possible clinical implications of therapeutically induced temperature changes in continuously monitored tumour mass. (Preliminary report). British journal of cancer, 1971, Volume: 25, Issue:1 Topics: Body Temperature; Breast Neoplasms; Circadian Rhythm; Female; Humans; Monitoring, Physiologic; Norethindrone; Prognosis; Skin Temperature; Thermography; Time Factors; Uterine Cervical Neoplasms	1971
The treatment of advanced carcinoma of the breast with SH 420. Clinical radiology, 1970, Volume: 21, Issue:2 Topics: Adult; Age Factors; Aged; Breast Neoplasms; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Norethindrone	1970
[Supplemental hormone treatment of operable breast neoplasms]. Langenbecks Archiv fur Chirurgie, 1970, Volume: 327, Issue:1 Topics: Adrenalectomy; Aged; Androgens; Breast Neoplasms; Female; Fluoxymesterone; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Norethindrone; Ovary; Sex Chromatin; Testosterone	1970
[Apropos of certain late and isolated cutaneous metastases from breast neoplasms]. Annales de dermatologie et de syphiligraphie, 1971, Volume: 98, Issue:1 Topics: Adenocarcinoma; Aged; Breast Neoplasms; Cyclophosphamide; Female; Humans; Middle Aged; Neoplasm Metastasis; Norethindrone; Skin Neoplasms	1971
[Treatment of inoperable and metastasizing breast cacinoma with gestagen hormones]. Munchener medizinische Wochenschrift (1950), 1967, Dec-08, Volume: 109, Issue:49 Topics: Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Norethindrone	1967
Drostanolone and norethisterone in disseminated breast cancer. Drug and therapeutics bulletin, 1969, Jan-31, Volume: 7, Issue:3 Topics: Androgens; Breast Neoplasms; Female; Humans; Norethindrone	1969
[Contribution of the norsteroids in the treatment of advanced breast cancer]. La Presse medicale, 1969, May-03, Volume: 77, Issue:22 Topics: Acetates; Breast Neoplasms; Drug Tolerance; Female; Humans; Hypercalcemia; Metrorrhagia; Norethindrone; Norsteroids	1969
Therapy by progestational agents in advanced breast cancer. The Medical journal of Australia, 1966, Feb-26, Volume: 1, Issue:9 Topics: Androgens; Breast Neoplasms; Diethylstilbestrol; Estrogens; Ethisterone; Female; Humans; Norethindrone; Progesterone	1966
Galactorrhea after contraceptive hormones. The New England journal of medicine, 1966, Jun-23, Volume: 274, Issue:25 Topics: Adenofibroma; Adult; Breast Neoplasms; Contraceptives, Oral; Female; Humans; Lactation Disorders; Mestranol; Norethindrone; Norethynodrel; Pregnancy	1966